Clinicopathological characteristics and prognosis of cervical cancer with different histological types: A population-based cohort study

Yifan Meng(Sun Yat-sen University), Tian Chu(Tongji Hospital), Shitong Lin(Tongji Hospital), Ping Wu(Tongji Hospital), Ping Wu(Tongji Hospital), Wenhua Zhi(Tongji Hospital), Ting Peng(Tongji Hospital), Wencheng Ding(Tongji Hospital), Danfeng Luo(Tongji Hospital), Peng Wu(Tongji Hospital), Peng Wu(Tongji Hospital)
Gynecologic Oncology
November 2, 2021
10.1016/j.ygyno.2021.10.007
Cited by 45

Abstract

Related Papers

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson et al.|The Lancet|2017|676
Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
Olusola Adegoke, Shalini Kulasingam, Beth A Virnig|Journal of Women s Health|2012|345
Prognostic significance of adenocarcinoma histology in women with cervical cancer
Vijaya Galic, Thomas J. Herzog, Sharyn N. Lewin et al.|Gynecologic Oncology|2012|274
Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy
Ke Hu, Weiping Wang, Xiaoliang Liu et al.|Radiation Oncology|2018|149
Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer
Kanyarat Katanyoo, Sompol Sanguanrungsirikul, Sumonmal Manusirivithaya|Gynecologic Oncology|2012|128